Trial · NCT01737697
Results by group270
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 270
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Exponential Rate of Change in Serum Potassium (S-K) Levels During the Initial 48 Hours of Study Drug Treatment. | Acute Phase: Placebo TID | Through 24 Hours | -0.00128 | Standard Error 0.000243 | log(mmol/L)/hour |
| Exponential Rate of Change in Serum Potassium (S-K) Levels During the Initial 48 Hours of Study Drug Treatment. | Acute Phase: Sodium Zirconium Cyclosilicate (ZS) 1.25 g TID | Through 24 Hours | -0.00187 | Standard Error 0.000250 | log(mmol/L)/hour |
| Exponential Rate of Change in Serum Potassium (S-K) Levels During the Initial 48 Hours of Study Drug Treatment. | Acute Phase: ZS 2.5 g TID | Through 24 Hours | -0.00205 | Standard Error 0.000263 | log(mmol/L)/hour |
| Exponential Rate of Change in Serum Potassium (S-K) Levels During the Initial 48 Hours of Study Drug Treatment. | Acute Phase: ZS 5 g TID | Through 24 Hours | -0.00280 | Standard Error 0.000250 | log(mmol/L)/hour |
| Exponential Rate of Change in Serum Potassium (S-K) Levels During the Initial 48 Hours of Study Drug Treatment. | Acute Phase: ZS 10 g TID | Through 24 Hours | -0.00382 | Standard Error 0.000258 | log(mmol/L)/hour |
| Exponential Rate of Change in Serum Potassium (S-K) Levels During the Initial 48 Hours of Study Drug Treatment. | Acute Phase: Placebo TID | Through 48 Hours | -0.00097 | Standard Error 0.000137 | log(mmol/L)/hour |
| Exponential Rate of Change in Serum Potassium (S-K) Levels During the Initial 48 Hours of Study Drug Treatment. | Acute Phase: Sodium Zirconium Cyclosilicate (ZS) 1.25 g TID | Through 48 Hours | -0.00110 | Standard Error 0.000141 | log(mmol/L)/hour |
| Exponential Rate of Change in Serum Potassium (S-K) Levels During the Initial 48 Hours of Study Drug Treatment. | Acute Phase: ZS 2.5 g TID | Through 48 Hours | -0.00163 | Standard Error 0.000148 | log(mmol/L)/hour |
| Exponential Rate of Change in Serum Potassium (S-K) Levels During the Initial 48 Hours of Study Drug Treatment. | Acute Phase: ZS 5 g TID | Through 48 Hours | -0.00223 | Standard Error 0.000141 | log(mmol/L)/hour |
| Exponential Rate of Change in Serum Potassium (S-K) Levels During the Initial 48 Hours of Study Drug Treatment. | Acute Phase: ZS 10 g TID | Through 48 Hours | -0.00321 | Standard Error 0.000145 | log(mmol/L)/hour |
| Exponential Rate of Change in S-K Levels in the Subacute Phase. | Subacute Phase: Placebo Matched to ZS 1.25 g QD | Through Day 8 | 0.00054 | Standard Error 0.004803 | log(mmol/L)/hour |
| Exponential Rate of Change in S-K Levels in the Subacute Phase. | Subacute Phase: ZS 1.25 g QD | Through Day 8 | 0.00874 | Standard Error 0.004308 | log(mmol/L)/hour |
| Exponential Rate of Change in S-K Levels in the Subacute Phase. | Subacute Phase: Placebo Matched to ZS 2.5 g QD | Through Day 8 | 0.01104 | Standard Error 0.004123 | log(mmol/L)/hour |
| Exponential Rate of Change in S-K Levels in the Subacute Phase. | Subacute Phase: ZS 2.5 g QD | Through Day 8 | 0.00734 | Standard Error 0.003642 | log(mmol/L)/hour |
| Exponential Rate of Change in S-K Levels in the Subacute Phase. | Subacute Phase: Placebo Matched to ZS 5 g QD | Through Day 8 | 0.01441 | Standard Error 0.003776 | log(mmol/L)/hour |
| Exponential Rate of Change in S-K Levels in the Subacute Phase. | Subacute Phase: ZS 5 g QD | Through Day 8 | 0.00581 | Standard Error 0.003918 | log(mmol/L)/hour |
| Exponential Rate of Change in S-K Levels in the Subacute Phase. | Subacute Phase: Placebo Matched to ZS 10 g QD | Through Day 8 | 0.02469 | Standard Error 0.003939 | log(mmol/L)/hour |
| Exponential Rate of Change in S-K Levels in the Subacute Phase. | Subacute Phase: ZS 10 g QD | Through Day 8 | -0.00053 | Standard Error 0.003877 | log(mmol/L)/hour |
| Exponential Rate of Change in S-K Levels in the Subacute Phase. | Subacute Phase: ZS 1.25 (Acute Phase: Placebo) | Through Day 8 | 0.00643 | Standard Error 0.004171 | log(mmol/L)/hour |
| Exponential Rate of Change in S-K Levels in the Subacute Phase. | Subacute Phase: ZS 2.5 g ( Acute Phase: Placebo) | Through Day 8 | 0.00390 | Standard Error 0.004023 | log(mmol/L)/hour |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01737697/results